Summary:
- Researchers at the Tata Memorial Centre in Mumbai have identified a new drug target for treating breast cancer. They discovered that a protein called LOXL2 is overexpressed in aggressive forms of breast cancer and plays a key role in tumor growth and metastasis.
- By inhibiting LOXL2, the researchers were able to slow down the growth and spread of breast cancer cells in laboratory experiments. This suggests that targeting LOXL2 could be a promising new approach for developing more effective breast cancer treatments.
- The findings have been published in the journal Nature Communications, and the researchers are now working on developing a drug that can specifically target and inhibit LOXL2 in breast cancer patients.